Extracellular vesicles (EVs) present a promising modality
for numerous
biological and medical applications, including therapeutics. Developing
facile methods to engineer EVs is essential to meeting the rapidly
expanding demand for various functionalized EVs in these applications.
Herein, we developed a technology that integrates enzymatic glycoengineering
and microfluidics for effective EV functionalization. This method
builds on a 3D nanostructured microfluidic device to streamline a
multiple-step EV engineering process, which involves a step of enzymatic
reaction to install azido-sialic acid residues to glycans on EVs using
a sialyltransferase and an azide-tagged sialyl donor followed by the
attachment of various functionalities, such as biotin and fluorescent
labels, to the resulting azido-glycans on EVs through a biocompatible
click reaction. Compared to traditional EV engineering methods, we
show that our technology improves the efficiency of EV glycoengineering
while simplifying and expediting the workflow. Furthermore, we demonstrated
the applicability of this technology to EVs derived from the cell
lines of different cancer types, including A549, PC3, and COLO-1 cells.
Overall, this EV engineering technology could provide a potentially
useful tool for broad applications.